Long cycle-life wound lithium-ion battery cells having metallized film current collectors
US-2024358635-A1 · Oct 31, 2024 · US
Methods for lowering blood glucose
US9295664B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9295664-B2 |
| Application number | US-201214124582-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 6, 2012 |
| Priority date | Jun 6, 2011 |
| Publication date | Mar 29, 2016 |
| Grant date | Mar 29, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
In one aspect, the invention relates to methods for treating muscle atrophy by providing to an animal in need thereof an effective amount of a compound. The compound can modulate the expression levels of multiple mRNA of a muscle atrophy signature. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of lowering blood glucose in an animal comprising administering to the animal a composition comprising from 25 to 500 mg of ursolic acid, and a compound having a structure represented by a formula: wherein each ----- represents a covalent bond selected from a single or double bond; wherein each of R 21a , R 21b , R 21c , R 21d , R 21e , R 22 , R 23a , R 23b , R 23c and R 23d in said formula is chosen independently from H and OH or a stereoisomer, tautomer, solvate, or pharmaceutically acceptable salt thereof; thereby lowering the blood glucose in the animal. 2. A method of lowering blood glucose in an animal comprising administering to the animal a composition comprising from 25 to 500 mg of ursolic acid, and a compound of formula:
Assignees
Inventors
Classifications
for hyperglycaemia, e.g. antidiabetics · CPC title
for glucose homeostasis (pancreatic hormones A61P5/48) · CPC title
Drugs for disorders of the muscular or neuromuscular system · CPC title
Anabolic agents (androgens A61P5/26) · CPC title
Muscle relaxants, e.g. for tetanus or cramps · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9295664B2 cover?
- In one aspect, the invention relates to methods for treating muscle atrophy by providing to an animal in need thereof an effective amount of a compound. The compound can modulate the expression levels of multiple mRNA of a muscle atrophy signature. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present inven…
- Who is the assignee on this patent?
- Adams Christopher M, Kunkel Steven D, Welsh Michael, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/353. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).